Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Improved Sprint Performance With Inhaled Long-Acting Β2-Agonists Combined With Resistance Exercise.

Merlini M, Whyte G, Marcora S, Loosemore M, Chester N, Dickinson J.

Int J Sports Physiol Perform. 2019 Apr 8:1-22. doi: 10.1123/ijspp.2018-0921. [Epub ahead of print]

PMID:
30958069
2.

The Effects of Inhaled Terbutaline on 3-km Running Time-Trial Performance.

Molphy J, Dickinson JW, Chester NJ, Loosemore M, Whyte G.

Int J Sports Physiol Perform. 2019 Jul 1;14(6):822–828. doi: 10.1123/ijspp.2018-0633.

PMID:
30569748
3.

The Effect of 400 µg Inhaled Salbutamol on 3 km Time Trial Performance in a Low Humidity Environment.

Molphy J, Dickinson JW, Chester NJ, Loosemore M, Whyte G.

J Sports Sci Med. 2017 Dec 1;16(4):581-588. eCollection 2017 Dec.

4.

Compounds with species and cell type specific toxicity identified in a 2000 compound drug screen of neural stem cells and rat mixed cortical neurons.

Malik N, Efthymiou AG, Mather K, Chester N, Wang X, Nath A, Rao MS, Steiner JP.

Neurotoxicology. 2014 Dec;45:192-200. doi: 10.1016/j.neuro.2014.10.007. Epub 2014 Oct 22.

5.

Acute impact of inhaled short acting b2-agonists on 5 km running performance.

Dickinson J, Hu J, Chester N, Loosemore M, Whyte G.

J Sports Sci Med. 2014 May 1;13(2):271-9. eCollection 2014 May.

6.

Impact of ethnicity, gender, and dehydration on the urinary excretion of inhaled salbutamol with respect to doping control.

Dickinson J, Hu J, Chester N, Loosemore M, Whyte G.

Clin J Sport Med. 2014 Nov;24(6):482-9. doi: 10.1097/JSM.0000000000000072.

PMID:
24518370
7.

Sequencing artifacts in the type A influenza databases and attempts to correct them.

Suarez DL, Chester N, Hatfield J.

Influenza Other Respir Viruses. 2014 Jul;8(4):499-505. doi: 10.1111/irv.12239. Epub 2014 Feb 7.

8.

The ergogenic effect of long-term use of high dose salbutamol.

Dickinson J, Molphy J, Chester N, Loosemore M, Whyte G.

Clin J Sport Med. 2014 Nov;24(6):474-81. doi: 10.1097/JSM.0000000000000076.

PMID:
24451697
9.

Prevalence of bronchoconstriction induced by eucapnic voluntary hyperpnoea in recreationally active individuals.

Molphy J, Dickinson J, Hu J, Chester N, Whyte G.

J Asthma. 2014 Feb;51(1):44-50. doi: 10.3109/02770903.2013.838256. Epub 2013 Oct 16.

PMID:
23987567
10.

Performance enhancing drug abuse and cardiovascular risk in athletes: implications for the clinician.

Angell PJ, Chester N, Sculthorpe N, Whyte G, George K, Somauroo J.

Br J Sports Med. 2012 Nov;46 Suppl 1:i78-84. doi: 10.1136/bjsports-2012-091186. Review.

11.

An alternate dietary strategy to make weight improves mood, decreases body fat and removes the necessity for dehydration: A case-study from a professional jockey.

Wilson G, Chester N, Eubank M, Crighton B, Drust B, Morton JP, Close GL.

Int J Sport Nutr Exerc Metab. 2012 Jun 15. [Epub ahead of print]

PMID:
22710736
12.

An alternative dietary strategy to make weight while improving mood, decreasing body fat, and not dehydrating: a case study of a professional jockey.

Wilson G, Chester N, Eubank M, Crighton B, Drust B, Morton JP, Close GL.

Int J Sport Nutr Exerc Metab. 2012 Jun;22(3):225-31.

PMID:
22693243
13.

Anabolic steroids and cardiovascular risk.

Angell P, Chester N, Green D, Somauroo J, Whyte G, George K.

Sports Med. 2012 Feb 1;42(2):119-34. doi: 10.2165/11598060-000000000-00000. Review.

PMID:
22229259
14.

Anabolic steroid use and longitudinal, radial, and circumferential cardiac motion.

Angell PJ, Chester N, Green DJ, Shah R, Somauroo J, Whyte G, George K.

Med Sci Sports Exerc. 2012 Apr;44(4):583-90. doi: 10.1249/MSS.0b013e3182358cb0.

PMID:
21900841
15.

Diurnal variation in the salivary melatonin responses to exercise: relation to exercise-mediated tachycardia.

Marrin K, Drust B, Gregson W, Morris CJ, Chester N, Atkinson G.

Eur J Appl Physiol. 2011 Nov;111(11):2707-14. doi: 10.1007/s00421-011-1890-7. Epub 2011 Mar 12.

PMID:
21399961
16.

Athletes' knowledge and views on OTC medication.

Mottram D, Chester N, Atkinson G, Goode D.

Int J Sports Med. 2008 Oct;29(10):851-5. doi: 10.1055/s-2008-1038403. Epub 2008 Apr 9.

PMID:
18401811
17.

Caffeine consumption amongst British athletes following changes to the 2004 WADA prohibited list.

Chester N, Wojek N.

Int J Sports Med. 2008 Jun;29(6):524-8. Epub 2007 Nov 16.

PMID:
18027309
18.

Bright light and thermoregulatory responses to exercise.

Atkinson G, Barr D, Chester N, Drust B, Gregson W, Reilly T, Waterhouse J.

Int J Sports Med. 2008 Mar;29(3):188-93. Epub 2007 Sep 13.

PMID:
17990214
19.

The Bloom's syndrome helicase is critical for development and function of the alphabeta T-cell lineage.

Babbe H, Chester N, Leder P, Reizis B.

Mol Cell Biol. 2007 Mar;27(5):1947-59. Epub 2007 Jan 8.

20.

Mutation of the murine Bloom's syndrome gene produces global genome destabilization.

Chester N, Babbe H, Pinkas J, Manning C, Leder P.

Mol Cell Biol. 2006 Sep;26(17):6713-26.

21.

Dose-dependent apoptotic and necrotic myocyte death induced by the beta2-adrenergic receptor agonist, clenbuterol.

Burniston JG, Chester N, Clark WA, Tan LB, Goldspink DF.

Muscle Nerve. 2005 Dec;32(6):767-74.

22.
23.

Chromosome instability and tumor predisposition inversely correlate with BLM protein levels.

McDaniel LD, Chester N, Watson M, Borowsky AD, Leder P, Schultz RA.

DNA Repair (Amst). 2003 Dec 9;2(12):1387-404.

PMID:
14642567
24.

Over-the-counter drug use amongst athletes and non-athletes.

Chester N, Reilly T, Mottram DR.

J Sports Med Phys Fitness. 2003 Mar;43(1):111-8.

PMID:
12629472
25.
27.

Casein kinase II phosphorylates I kappa B alpha at S-283, S-289, S-293, and T-291 and is required for its degradation.

McElhinny JA, Trushin SA, Bren GD, Chester N, Paya CV.

Mol Cell Biol. 1996 Mar;16(3):899-906.

30.

Mutational mapping of RAS-responsive domains of the Saccharomyces cerevisiae adenylyl cyclase.

Colicelli J, Field J, Ballester R, Chester N, Young D, Wigler M.

Mol Cell Biol. 1990 Jun;10(6):2539-43.

31.

N myristylation of the human immunodeficiency virus type 1 gag polyprotein precursor in Saccharomyces cerevisiae.

Bathurst IC, Chester N, Gibson HL, Dennis AF, Steimer KS, Barr PJ.

J Virol. 1989 Jul;63(7):3176-9.

32.

Regional sensitivity of neuroleptic receptors to sub-acute soman intoxication.

Valdes JJ, Chester NA, Menking D, Shih TM, Whalley C.

Brain Res Bull. 1985 Feb;14(2):117-21.

PMID:
3995358

Supplemental Content

Loading ...
Support Center